Literature DB >> 9274913

Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.

N Oridate1, S Suzuki, M Higuchi, M F Mitchell, W K Hong, R Lotan.   

Abstract

BACKGROUND: The inhibitory effects of N-(4-hydroxyphenyl)retinamide (4HPR) on tumorigenesis and tumor growth may result from its ability to induce apoptosis (programmed cell death). Since antioxidants inhibit 4HPR-induced apoptosis, experiments were planned to determine whether the levels of reactive oxygen species increase in cells undergoing apoptosis after exposure to 4HPR.
METHODS: Cells of the human cervical carcinoma cell line C33A and normal human cervical epithelial cells were treated with 4HPR and analyzed for survival, induction of apoptosis, generation of reactive oxygen species, and expression of the apoptosis-related proteins Bcl-2 and Bax.
RESULTS: Treatment with 4HPR decreased C33A cell number by inducing apoptosis in a time- and dose-dependent fashion. DNA fragmentation typical of apoptosis was observed in cells exposed to 4HPR at concentrations of 3 microM or higher for 6-24 hours. The generation of reactive oxygen species was enhanced by 1.85-fold to 4.5-fold after a 1.5-hour treatment with 0.4-10 microM 4HPR. Pyrrolidine dithiocarbamate, an oxygen radical scavenger, suppressed the rate of generation of reactive oxygen species and inhibited 4HPR-induced apoptosis. 4HPR failed to modulate cellular levels of the Bcl-2 and Bax proteins. N-(4-Methoxyphenyl)retinamide, the major 4HPR metabolite, and several other retinoids that bind to nuclear retinoic acid receptors or retinoid X receptors failed to enhance the generation of reactive oxygen species and to induce apoptosis. 4HPR was much less effective in generating reactive oxygen species and in inducing apoptosis in normal human cervical epithelial cells than in C33A cervical carcinoma cells.
CONCLUSIONS: Enhancement of the generation of reactive oxygen species may be involved in apoptotic pathway induction by 4HPR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274913     DOI: 10.1093/jnci/89.16.1191

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  35 in total

1.  The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.

Authors:  Numsen Hail; Ping Chen; Michael F Wempe
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

2.  All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Authors:  Amareshwar T K Singh; Andrew M Evens; Reilly J Anderson; Jennifer A Beckstead; Natesan Sankar; Antonella Sassano; Savita Bhalla; Shuo Yang; Leonidas C Platanias; Trudy M Forte; Robert O Ryan; Leo I Gordon
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

3.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

Review 4.  Chemoprevention of breast cancer with fenretinide.

Authors:  R Torrisi; A Decensi; F Formelli; T Camerini; G De Palo
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial.

Authors:  Ann M Mohrbacher; Allen S Yang; Susan Groshen; Shivaani Kummar; Martin E Gutierrez; Min H Kang; Denice Tsao-Wei; C Patrick Reynolds; Edward M Newman; Barry J Maurer
Journal:  Clin Cancer Res       Date:  2017-04-18       Impact factor: 12.531

6.  Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide.

Authors:  Nadine Darwiche; Ghada Abou-Lteif; Tarek Najdi; Lina Kozhaya; Ahmad Abou Tayoun; Ahmad Abou Tayyoun; Ali Bazarbachi; Ghassan S Dbaibo
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

7.  Fenretinide induces ubiquitin-dependent proteasomal degradation of stearoyl-CoA desaturase in human retinal pigment epithelial cells.

Authors:  William Samuel; R Krishnan Kutty; Todd Duncan; Camasamudram Vijayasarathy; Bryan C Kuo; Krysten M Chapa; T Michael Redmond
Journal:  J Cell Physiol       Date:  2014-08       Impact factor: 6.384

8.  Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability.

Authors:  Xin Li; Wen Ling; Angela Pennisi; Sharmin Khan; Shmuel Yaccoby
Journal:  Cancer Lett       Date:  2009-05-15       Impact factor: 8.679

9.  Oral lichen planus treated with 13-cis-retinoic acid (isotretinoin): effects on the apoptotic process.

Authors:  Adriano Piattelli; Francesco Carinci; Giovanna Iezzi; Vittoria Perrotti; Gaia Goteri; Massimiliano Fioroni; Corrado Rubini
Journal:  Clin Oral Investig       Date:  2007-05-05       Impact factor: 3.573

10.  Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells.

Authors:  Kankan Wang; Hai Fang; Dakai Xiao; Xuehua Zhu; Miaomiao He; Xiaoling Pan; Jiantao Shi; Hui Zhang; Xiaohong Jia; Yanzhi Du; Ji Zhang
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.